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Time-of-flight reconstruction mitigates the 
errors introduced by respiratory state mis-
match in the attenuation map in recon-
structed PET images.
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Purpose: To evaluate the magnitude and anatomic extent of the arti-
facts introduced on positron emission tomographic (PET)/
magnetic resonance (MR) images by respiratory state 
mismatch in the attenuation map.
Materials and 
Methods:
The method was tested on 14 patients referred for an 
oncologic examination who underwent PET/MR imaging. 
The acquisition included standard PET and MR series for 
each patient, and an additional attenuation correction 
series was acquired by using breath hold. PET data were 
reconstructed with and without time-of-flight (TOF) in-
formation, first by using the standard free-breathing at-
tenuation map and then again by using the additional 
breath-hold map. Two-tailed paired t testing and linear 
regression with 0 intercept was performed on TOF ver-
sus non-TOF and free-breathing versus breath-hold data 
for all detected lesions.
Results: Fluorodeoxyglucose-avid lesions were found in eight of the 
14 patients included in the study. The uptake differences 
(maximum standardized uptake values) between PET 
reconstructions with free-breathing versus breath-hold 
attenuation ranged, for non-TOF reconstructions, from 
218% to 26%. The corresponding TOF reconstructions 
yielded differences from 215% to 18%.
Conclusion: TOF information was shown to reduce the artifacts caused 
at PET/MR by respiratory mismatch between emission 
and attenuation data.
q RSNA, 2016
Online supplemental material is available for this article.
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as-yet-unpublished study. In our study, 
we report on the effect of respiratory 
motion and TOF on ungated datasets.
Data Acquisition
All patients were injected an average 
dose of 3.3 MBq/kg 6 0.3 (range, 
3.0–3.8 MBq/kg) fluorine 18 fluorode-
oxyglucose (FDG). An uptake time of 
approximately 40 minutes was allowed 
before the patients underwent a PET/
MR examination, and the protocol was 
set up so that the PET acquisition would 
start after 60 minutes of uptake time.
The acquisition protocol varied de-
pending on the indication, including 
both single and multibed examinations 
with PET acquisition times ranging 
from 2 to 8 minutes per bed position 
(eg, depending on the presence or 
absence of triggered MR sequences). 
Clinical MR sequences were performed 
simultaneously with each PET bed and 
with an automated attenuation correc-
tion sequence (Lava Flex, GE Health-
care; dual-echo spoiled gradient-re-
called acquisition in the steady state; 
256 3 128 3 120 matrix; 1.95 3 1.95 
3 2.6 mm3 resolution; imaging time, 18 
seconds). This sequence was by default 
performed during free breathing.
In each patient, after completion of 
the PET task in the thorax, the exami-
nation was repeated with the same geo-
metrical settings, instructing the patient 
to perform an end-expiratory breath 
MR-based attenuation map. This study 
evaluates the magnitude and anatomic 
extent of the artifacts introduced in 
PET/MR images by respiratory state 
mismatch in the attenuation map.
Materials and Methods
GE Healthcare (Waukesha, Wis) pro-
vided technical support for this study. 
Authors who are not employees of or 
consultants for GE Healthcare had con-
trol of inclusion of any data that might 
present a conflict of interest.
Patient Population
Datasets from 14 patients from the nu-
clear medicine department were used 
in this study. Patients were included 
when they were suspected of having 
pulmonary lesions (benign or malig-
nant) on the basis of the clinical indi-
cation or referral information and/or 
when patients had known lesions from 
previous imaging. All patients were in-
cluded consecutively. No patients were 
excluded from this consecutive series.
The patient population consisted 
of 10 men (mean age 6 standard de-
viation, 64 years 6 11; range, 36–79 
years) and four women (mean age, 
64 years 6 3; range, 58–67 years). 
Student t test revealed no statisti-
cally significant difference between 
these group averages. The average 
population age was 64 years 6 10 
(age range, 36–79 years), weight was 
75 kg 6 14 (range, 54–102 kg), and 
body mass index was 25.8 kg/m2 6 
3.6 (range, 21.5–35.7 kg/m2). Patients 
were imaged with the same PET/ 
MR imager (Signa PET/MR; GE Health-
care). This prospective study and data 
acquisition were approved by the lo-
cal ethics committee, and all patients 
provided written informed consent be-
fore the examination. Eight of the 14 
patients were included in a separate, 
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Advance in Knowledge
 n Time-of-flight (TOF ) information 
was found to reduce the magni-
tude of respiratory mismatch 
artifacts from a range of 218% 
to 26% to a range of 215% to 
18%.
Implication for Patient Care
 n Our reported results demon-
strated the benefit of TOF recon-
struction for the minimization of 
the residual misalignment 
artifacts.
The latest generation of clinical pos-itron emission tomography (PET)/magnetic resonance (MR) imagers 
introduces a new detector technology 
on the basis of silicon photomultipliers. 
This technology offers superior timing 
performance (1,2), which allows for 
time-of-flight (TOF) PET imaging.
TOF technology is not new or exclu-
sive of PET/MR. Its effect on PET/com-
puted tomographic (CT) imaging was 
thoroughly studied (3–6). It is known 
to provide an improvement of signal-to-
noise ratio inversely proportional to the 
timing resolution of the system, which 
yields a better tradeoff between acqui-
sition time, image noise, and structural 
contrast. It also improves imaging per-
formance for heavier patients, which 
results in more uniform quality over all 
patient sizes.
However, a less known benefit of 
TOF makes it ideally suited for PET/MR 
imaging: Because TOF detectors narrow 
down the possible origin of positron 
emissions, the reconstruction becomes 
better conditioned and more likely to 
provide a globally optimal solution de-
spite the presence of inaccuracies in the 
measured data and/or system model 
(7–9). In other words, PET becomes 
more robust to mistakes in the atten-
uation map. This property is of partic-
ular relevance in PET/MR imaging be-
cause MR-based attenuation correction 
is generally less accurate than its PET/
CT counterpart (10–13). Not only are 
the attenuation coefficients a priori es-
timates rather than measurements, but 
there are also several sources of arti-
facts that can affect the attenuation map 
(14,15): field-of-view truncation, fat-wa-
ter swaps, metal artifacts, and others.
For the particular case of the thorax, 
there is an intrinsic mismatch because 
of respiratory motion between PET 
emission data and the corresponding 
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Results
The reconstructed PET emission images 
(Fig E1 [online]) were analyzed by two 
radiologists (F.B. and T.S., with 7 and 
10 years of experience, respectively) and 
one radiologist and nuclear medicine 
physician (M.H., with 8 years of experi-
ence) by using a work station (Advantage 
Workstation; GE Healthcare) with the 
standard clinical oncology review proto-
col. FDG-avid lesions were found in eight 
of the 14 patients included in the study, 
five of the remaining patients showed no 
noticeable lesions, and one patient pre-
sented with a lesion that was not FDG 
avid (ie, cyst or hemangioma) in the 
liver. Figure 1 includes the reconstructed 
PET emission data for this FDG-nega-
tive lesion, including free-breathing and 
breath-hold attenuation correction data. 
A summary of all encountered lesions is 
included in Table E1 (online).
Three of the 14 patients (patients 
1, 8, and 10) were found to have per-
formed an inspiratory breath hold 
rather than the nonforced end-expira-
tion breath hold they were instructed to 
perform. This situation leads to much 
larger anatomic mismatch between the 
MR and PET datasets. These patients 
lungs (0.018 cm21) are fixed, whereas 
those of other tissues were a weighted 
average of their fat (0.086 cm21) and 
soft tissue (0.100 cm21) composition. 
Patient tissue outside the 50-cm field 
of view (Lava Flex) was automatically 
identified from a non-attenuation-cor-
rected PET reconstruction and assigned 
soft tissue-equivalent attenuation.
A second PET reconstruction exam-
ination was performed in each patient 
(ie, free-breathing and breath-hold 
MR-based attenuation correction), 
this time by using a three-dimensional 
algorithm (Osem; VuePoint FX) that 
took into account the TOF information 
to take advantage of the less-than-
400-picosecond timing resolution of 
the detectors (16).
Statistical Methods
Parameters obtained from lesions (size, 
maximum standardized uptake value, 
and mean standardized uptake value) 
were analyzed by using software 
(Prism, Graphpad Software, La Jolla, 
Calif; and Excel, Microsoft, Redmond, 
Wash). Two-tailed paired t testing and 
linear regression with 0 intercept was 
performed on TOF versus non-TOF and 
free-breathing versus breath-hold data.
hold (ie, “please breathe in… breathe 
out… hold your breath”) during the 
attenuation correction sequence. PET 
data from this second acquisition were 
discarded.
Data Processing
PET images were reconstructed for the 
bed positions that covered the thorax 
by using a three-dimensional ordered-
subset expectation maximization 
method (VuePoint HD; GE Healthcare) 
with four iterations and 28 subsets onto 
a 256 3 256 3 89 matrix with voxel 
size of 2.34 3 2.34 3 2.78 mm3. The 
reconstructed images were filtered by 
using a transaxial Gaussian filter (5-
mm full width at half maximum) fol-
lowed by a three-section axial filter (ra-
tio of 1:4:1). Quantitative corrections 
applied during image reconstruction 
included normalization, dead time, 
point-spread function, randoms, scat-
ter, decay, and attenuation. The latter 
was based on a four-tissue-class (air, 
lung, fat, and soft tissue) segmented 
attenuation map, automatically gener-
ated from the results of the MR-based 
attenuation correction acquisition (Lava 
Flex; GE Healthcare) (13). The atten-
uation coefficients for air (0 cm21) and 
Figure 1
Figure 1: Sagittal PET images in two patients. (a) Images in patient 2 show one of the FDG-avid pleural lesions. (b) 
Images in patient 8 show the FDG-negative lesion in the apex of the liver. The top row shows reconstructions that use 
free-breathing attenuation correction data, the bottom row shows reconstructions that use breath-hold attenuation 
correction data (inspiratory breath hold). The views on the left column were reconstructed by using TOF information and 
the views on the right were reconstructed without TOF information.
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Discussion
We compared the two MR-based at-
tenuation correction options currently 
available for the thoracic region: free-
breathing and breath-hold automated 
attenuation correction sequence (Lava 
Flex; GE Healthcare). Our patients 
were instructed to perform a standard, 
nonforced, end-expiration breath hold 
because it provides the closest approxi-
mation to the quiescent phase of the re-
spiratory cycle. Three patients errone-
ously performed an inspiratory breath 
hold, which is known to lead to large 
anatomic mismatch. We include these 
results in a separate group because this 
is not an uncommon situation in clinical 
practice, especially in oncology where 
patients are usually elderly and compli-
ance issues frequently arise.
Because of the lack of a standard 
reference, the difference between free-
breathing and breath-hold MR-based 
attenuation correction was used as an 
estimate of the expected error range 
caused by respiratory mismatch. No-
tice that PET/CT data would still not 
constitute a standard of reference. 
Barring sophisticated approaches not 
used in clinical practice (eg, attenua-
tion correction on the basis of dynamic 
CT) (17–20), there is no practical way 
to estimate patient attenuation in the 
presence of respiratory motion.
Voxel-wise maps offer the most intu-
itive representation of the bias that re-
spiratory mismatch can introduce in PET 
(Figs E2–E5 [online]). Notice how nor-
malized error values larger than 610% 
can be found over the entire lung con-
tour. These results agree with previously 
published PET/CT results (21). These 
results are particularly important for 
routine clinical reading. While the arti-
facts, for example, shown in Figure 1 can 
be readily identified as such, lesions of 
intermediate size can completely disap-
pear and might therefore lead to a mis-
diagnosis. In case of follow-up studies, 
such errors can lead to misinterpretation 
because standardized uptake value mea-
surements are likely to be inconsistent for 
lesions located in areas affected by respi-
ratory mismatch. Such misinterpretation 
(ie, stable vs progressive or regressive 
versus breath-hold attenuation maps 
ranged from 215% to 18% for TOF re-
constructions. The corresponding non-
TOF reconstructions yielded differ-
ences from 218% to 26%. The mean 
standardized uptake value differences 
ranged from 214% to 16% for TOF and 
from 219% to 18% for non-TOF values. 
Table 2 summarizes these results. 
The statistical power was insufficient 
to determine the significance of these 
trends because of the reduced sample 
size with respect to all possible lesion 
placements and artifact configurations 
(paired t testing; maximum and min-
imum standardized uptake value ab-
solute differences, P = .03 and .08, 
respectively). Figure 2 also shows 
the scatterplot of the normalized dif-
ferences between free-breathing and 
breath-hold MR-based attenuation 
correction.
The results of voxel-wise comparison 
between the different reconstructions 
are included as supplementary material 
(Figs E2–E5 [online]). The percent nor-
malized error was used and presented as 
´ = 100 ∙ (I2 2 I1)/I1, where I1 is the im-
ager’s original (ie, free-breathing) recon-
struction and I2 is the new (ie, breath-
hold) reconstruction. Regions of low 
uptake (,500 Bq/mL) were excluded.
The distribution of the uptake dif-
ferences between free-breathing and 
breath-hold MR-based attenuation 
correction reconstructions are pre-
sented in Figure 3a and 3b. Separate 
log-histograms are provided for end-
expiration breath-hold and inspiratory 
breath-hold patients. A different rep-
resentation of these same results can 
be found in Figure 3c and 3d, where 
cumulative distribution functions of the 
absolute uptake differences are shown. 
The presented graphs are the average 
of the individual curves measured for 
all patients. These differences indicate 
errors in the reconstructed PET uptake 
caused by anatomic mismatch in the at-
tenuation maps; the figures show that, 
in TOF reconstructions, roughly 90% of 
the image voxels have absolute errors 
of 10% or less (an acceptable range for 
most clinical applications). In non-TOF 
reconstructions, only 82% of the image 
voxels are below 10% absolute error.
were excluded from the subsequent 
analysis and studied separately.
The size and FDG uptake of each 
lesion were measured on the recon-
structed PET emission datasets by us-
ing the auto-contour tool provided by 
the workstation (Advantage Worksta-
tion; GE Healthcare). Lesion sizes and 
uptakes on the clinical standard dataset 
(free-breathing MR-based attenuation 
correction, and TOF reconstruction) 
are summarized in Table 1. Non-TOF 
reconstructions yielded noticeably 
larger sizes and lower uptake (statisti-
cal significance confirmed by two-tailed 
paired t test; P , .01). These differ-
ences were especially relevant for very 
small lesions (,2 cm3).
Figure 2 shows the analysis of the 
scatterplots of the standardized up-
take value of the lesions measured on 
TOF and non-TOF reconstructions. The 
value of each lesion is included twice, 
once measured on reconstructions by 
using free-breathing attenuation cor-
rection and once again measured on 
reconstructions by using breath hold. 
Both maximum and mean standardized 
uptake value plots showed good correla-
tion between TOF and non-TOF values 
(R2 . 0.9), and TOF uptake values had 
a trend that was approximately 10% 
higher than non-TOF uptake values.
The differences in maximum stan-
dardized uptake values between PET 
reconstructions with free-breathing 
Table 1
Summary of Lesion Sizes and 
Uptakes, Measured with the Clinical 
Standard (ie, Free-Breathing) 
Datasets
Parameter Non-TOF TOF
All lesions
 Size (cm3) 3.0 6 2.5 2.1 6 2.3 
 SUVmax 4.8 6 3.9 5.6 6 4.1
 SUVmean 2.9 6 2.2 3.4 6 2.2
Small lesions 
 Size (cm3) 1.8 6 0.7 0.9 6 0.4
 SUVmax 4.9 6 4.7 5.9 6 4.8
 SUVmean 3.0 6 2.6 3.6 6 2.6
Note.—Small lesions were considered to be lesions less 
than 2 cm3. SUVmax = maximum standardized uptake 
value, SUVmean = mean standardized uptake value.
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findings (8,9,22,23) and are explained by 
the additional constraints imposed on the 
reconstruction by TOF information.
The decision regarding whether 
generalized small-magnitude errors are 
preferable to localized large-magnitude 
ones belongs to the clinician on the ba-
sis of the needs of each clinical applica-
tion. For the particular case of oncologic 
whereas small errors dominate in TOF 
reconstructions. This is also shown in 
the supplementary figures (Fig E1–E5 
[online]), where TOF reconstructions 
show small magnitude errors spread over 
large areas, compared with non-TOF re-
constructions that show errors of larger 
magnitude but over smaller areas. These 
results are consistent with previous 
disease) can have an effect on the thera-
peutic management of patients. Overall, 
there might be a slightly increased risk of 
initial mischaracterization and misinter-
pretation of the effect of a therapy.
The effect of the use of TOF recon-
struction is best appreciated in the error 
plot (Fig 3). The high error range is dom-
inated by the non-TOF reconstruction, 
Figure 2
Figure 2: (a, b) Scatterplots of the maximum (a) and mean (b) standardized uptake (SUV
max
 and SUV
mean
, respectively) of the FDG-avid lesions found in the patients 
measured on TOF and non-TOF reconstructions. The value of each lesion is included twice, once measured on reconstructions by using free-breathing attenuation 
correction and once again measured on reconstructions by using breath-hold attenuation correction. (c, d) Scatterplots of the normalized differences between free-
breathing and breath-hold attenuation of maximum (c) and mean (d) standardized uptake value. The regression line shows a slope smaller than 1, which suggests 
that TOF reconstruction provides more consistent results in the presence of attenuation map variation.
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staging, where uptake measurements of 
localized structures are sought, TOF in-
formation seems clearly advantageous. 
This is because the clinical influence of 
this effect is smaller because the mag-
nitude of error itself is smaller and it 
affects the image more homogeneously.
The TOF property of robustness to 
inconsistencies between emission and at-
tenuation data are of particular relevance 
for PET/MR imaging and needs revisit-
ing within this new context. Indeed, the 
estimation of photon attenuation (both 
Table 2
Summary of Lesion Uptake Differences between PET Reconstructions with  
Free-breathing and Breath-hold Attenuation Correction
Parameter
Normalized Error Absolute Normalized Error*
Non-TOF TOF Non-TOF TOF
SUVmax 0 6 10 0 6 6 7 6 7 4 6 5
SUVmean 22 6 8 0 6 6 6 6 6 4 6 4
Note.—Data are percentages. These values constitute an estimate of the expected error ranges caused by respiratory mismatch. 
SUVmax = maximum standardized uptake value, SUVmean = mean standardized uptake value.
* Significantly different: maximum standardized uptake value, P = .03; mean standardized uptake value, P = .08.
Figure 3
Figure 3: Plots of PET normalized error between free-breathing and breath-hold attenuation correction. (a) Patients who performed a nonforced 
expiratory breath hold (BH) during the acquisition of the attenuation correction MR sequence. (b) Patients who performed an inspiratory breath hold. 
The frequency axis (a, b) indicates the number of voxels affected by each error magnitude (in logarithmic scale). (c, d) Cumulative distribution functions 
of the absolute normalized PET error, averaged over all patients: (c) nonforced expiratory breath hold and (d) inspiratory breath hold.
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are generally less accurate than PET/CT 
(see Fig E1 [online]) and are prone to 
artifacts (eg, motion, metallic implants, 
and truncation). For the particular case 
of the thorax, PET emission data will (in 
the absence of gating) be an average of all 
respiratory states, whereas respiratory 
motion in MR causes ghosting artifacts 
rather than averaging.
The main limitations of this study 
were the reduced patient population, 
which prevented a stratified statistical 
analysis of the artifacts, and the absence 
of gated reconstructions in the compar-
ison. Ongoing work is aimed at extend-
ing this study to gated PET acquisitions, 
where both the negative effect of ana-
tomical misalignment and the benefit of 
breath-hold attenuation correction are 
expected to be more noticeable. In par-
ticular, it would be of interest to evaluate 
the effect of TOF in patients with very 
shallow or irregular breathing patterns 
(common in certain clinical indications), 
where the accuracy of gating and motion 
correction approaches may be limited.
The results presented here support 
the premise that TOF reconstruction 
mitigates the errors introduced in re-
constructed PET images by respiratory 
state mismatch in the attenuation map 
(maximum standardized uptake value 
errors ranged from 218% to 26% for 
non-TOF and from 215% to 18% for 
TOF). These errors were confirmed to 
exceed the clinically acceptable range, 
not only in the vicinity of the diaphragm 
but all over the lung contour.
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